Poly(ADP-ribose) polymerase 1 (PARP1) is both a first responder to DNA damage and a 12 chromatin architectural protein. How PARP1 rapidly finds DNA damage sites in the context of a 13 nucleus filled with undamaged DNA, to which it also binds, is an unresolved question. Here we 14 show that PARP1 association with DNA is diffusion-limited, and release of PARP1 from DNA is 15 promoted by binding of an additional DNA molecule that facilitates a "monkey bar" mechanism, 16 also known as intersegment transfer. The WGR-domain of PARP1 is essential to this 17 mechanism, and a point mutation (W589A) recapitulates the altered kinetics of the domain 18 deletion. Demonstrating the physiological importance of the monkey bar mechanism for PARP1 19 function, the W589A mutant accumulates at sites of DNA damage more slowly following laser 20 micro-irradiation than wild-type PARP1. Clinically relevant inhibitors of PARP1 did not alter the 21 rate or mechanism of the release of PARP1 from DNA. 22 23 24 33 ovarian and/or breast cancer in BRCA1/2 negative patients, and there are many on-going phase 34 III clinical trials for inhibitors of PARPs either as monotherapy or in combination with chemo-or 35 radiotherapy.
Introduction 25
Poly(ADP-ribose) polymerase 1 (PARP1) serves as a first responder to DNA damage and is the 26 founding member and most abundant representative of the large family of diphtheria toxin-like 27 ADP-ribosyltransferases (ARTDs) 1-7 . Binding to either single or double-strand DNA breaks 28 (SSBs or DSBs) enzymatically activates PARP1 to use NAD + in polymerizing long chains of 29 poly(ADP)-ribose (PAR) onto itself and other nuclear acceptor proteins such as histones and 30 DNA repair proteins. These PAR chains then recruit the appropriate DNA repair machinery 31 containing PAR-binding motifs 8, 9 . PARP1 is of special interest because it is a validated target for 32 cancer therapy 10, 11 . Most notably, olaparib and rucaparib are in clinical use for treatment of 1 maintained by Zn1, while the Zn3 and WGR domains make additional contacts to the DNA (Fig also have significant affinity. PARP1 must rapidly search the genome for damaged DNA, yet it 23 has significant affinity for the billions of base pairs of undamaged DNA that are present at 24 concentrations of ~100 mg/mL in the nucleus 28 . In fact, laser micro-irradiation experiments in 25 live cells have shown that PARP1 significantly accumulates at DNA damage sites in less than 26 10 seconds 29 . The conundrum is that repeated cycles of release of PARP1 from undamaged 27 DNA, random diffusional collisions, and rebinding to a different location may not be fast enough 28 to explain how PARP1 can rapidly localize to sites of DNA damage. Various models have been 29 put forth and tested for explaining how "facilitated diffusion" could accelerate this search 30 process, all of which recognize the importance, as opposed to hindrance, of non-specific binding 31 to DNA for efficient site localization 27, [30] [31] [32] . These models include binding followed by one-32 dimensional sliding along DNA, hopping to a near-by site in the same chain, and intersegment 33 transfer via an intermediate loop that is formed when the protein binds two different DNA sites at 34 the same time. While some localized sliding along DNA has been reported for PARP1 23 , a more 35 thorough kinetic characterization of binding to and dissociation from DNA is needed in order to 36 address how PARP1 can efficiently localize to sites of DNA damage to initiate repair.
38
PARP1 has been found to associate more tightly with DNA in vivo in the presence of clinically 39 relevant inhibitors. This phenomenon, known as PARP "trapping" 10,33-36 is thought to be in part 40 responsible for the clinical effects of PARP inhibitors and has been used to explain the 41 numerous discrepancies between in vitro inhibition of PARP1 vs. potency in preclinical models.
42
For example, talazoparib is 100-fold more potent at trapping PARP1 on DNA and >50-fold more 43 potent at killing cancer cells than rucaparib and olaparib, although the apparent IC-50's for all 44 three compounds are quite similar (1 -5 nM) 34 . Further complicating matters, extensive 45 biochemical investigations of PARP1 trapping failed to provide evidence for an allosteric 46 interaction between DNA-and inhibitor-binding 37 , suggesting that trapping is due solely to inhibition of catalytic activity (but see 16 ). Thus an evaluation of PARP inhibitors in a quantitative 48 assay that measures DNA binding and release has the potential to shed further light on this 49 controversial issue. 50 51 1 association of PARP1 with DNA is extremely fast, and that dissociation depends on the 2 formation of a ternary complex where a second DNA molecule binds before release of the 3 original DNA. We find that the WGR-domain, more specifically the conserved residue Trp589, is 4 essential for triggering DNA-dependent release of DNA from PARP1, and we demonstrate the 5 importance of this mechanism of DNA release for the accumulation of PARP1 at sites of DNA 6 damage in the cell. Finally, we find that clinically relevant inhibitors do not perturb the rate or 7 mechanism of release of DNA from PARP1.
9
Materials and Methods
11
Materials 12 NAD + was obtained from Sigma. Olaparib, veliparib, niraparib, and talazoparib were obtained 13 from Selleck. DNA oligonucleotides and their complementary strands were obtained from IDT: 14 p18mer: 5'-phosphate-GGGTTGCGGCCGCTTGGG-3'. Labeled oligonucleotides with a 5'-15 fluorescein dye (*) were also obtained from IDT. Double-stranded fragments were prepared by 16 annealing at 100 µM DNA in 10 mM Tris-HCl (pH 7.5), 100 mM NaCl, and 0.1 mM EDTA. The
17
DNA was heated to 95°C for 5 min and then slowly cooled at 0.1°C/second to 4°C. Annealing 18 was confirmed by 10% (wt/vol) native TBE-PAGE at 200 V for 30 minutes.
20
Cloning of Deletion Constructs ∆Zn1, ∆Zn2, ∆Zn3, and ∆WGR of PARP1
21
The pET28a vector encoding cDNA of full length human PARP1 was used to design constructs 22 lacking various domains of PARP1 following the method outlined in Hansson et al 38 . Briefly, 23 primer 1 was designed as a reverse complement of the sequence that corresponds to 20-25 24 bases upstream of the DNA sequence to be deleted, followed by 20-25 bases corresponding to 25 the downstream sequence. Primer 2 corresponds to the complementary strand. These primers 26 were used in a PCR reaction to loop out the DNA encoding individual domains of PARP1: ∆Zn1 27 (M1-K97), ∆Zn2 (G96-linker-K207), ∆n3 (G215-linker-A367), and ∆WGR (N517-linker-L655).
28
After PCR, DpnI digestion was used to degrade the template plasmid and was then transformed 29 to generate clones. Next, a linker DNA sequence encoding amino acids LLA(GS)4GAAL was 30 inserted in place of the deleted domain using partially overlapping primers comprising the entire 31 sequence of the insert followed by 20-25 bases of the downstream sequence. Thereafter, 32 another step of insertion of linker DNA sequence encoding amino acids ALA (GS)5GLAL 33 upstream of the previous insert was performed in a similar manner. The plasmids used to 34 express various domain deletion PARP1 mutants eventually all contained the 30 amino acid 35 linker ALA (GS)5GLALLLA(GS)4GAAL in place of the deleted PARP1 domain. The W589A 36 mutant of PARP1 was generated using QuikChange Mutagenesis (Agilent) following the 37 manufacturer's instructions. All constructs were verified by DNA sequencing of the entire 38 PARP1 gene.
40

Expression and Purification of PARP1
41
Wild-type PARP1, all deletion constructs, and the W589A mutant of PARP1 were expressed 42 and purified from E. coli as previously described 21, 39 with the minor modification that PARP1 was 43 eluted from the nickel-NTA column using a gradient from 20 -400 mM imidazole.
45
Activity and Stability Measurements of PARP1
46
PARylation activity was evaluated by incubating 1 µM PARP1 with 1 µM p18mer and 500 µM 47 NAD + in 50 mM Tris-HCl (pH 7.5), 50 mM NaCl, and 1 mM MgCl2, for 5 min. Reactions were 48 quenched in Laemmli buffer, boiled for 5 min, and then resolved on SDS-PAGE (4 -20%). PARP1 stability was evaluated using the Protein Thermal Shift Dye Kit from Applied Biosystems 1 and a BioRad C1000 ThermalCycler with a CFX96 RealTime module.
3
Stopped-Flow Fluorescence Anisotropy
4
A SX20 Stopped-Flow Spectrometer (Applied Photophysics) was used for measuring 5 fluorescence anisotropy using an excitation wavelength of 485 nm and cut-off filters in the 6 parallel and perpendicular detectors at 515 nm. Association reactions were measured by mixing 7 equal volumes of p18mer* (60 nM) with 3 -8 different concentrations of PARP1 (60 -250 nM) 8 and monitoring the anisotropy at 20°C for 25 ms. All indicated concentrations are after mixing.
9
Although PARP1 can bind to both ends of p18mer* (and p18mer) simultaneously 15 , we treat 10 each DNA oligomer as one equivalent (not two) because fluorescence anisotropy detects only 11 the first binding event.Control reactions used for determining background signal lacked PARP1.
12
For measuring dissociation, a pre-formed complex of PARP1 (37 nM) and p18mer* (50 nM) was 
47
Results 48 Association of PARP1 with DNA is extremely fast
49
We began our investigations by measuring the rate of association of PARP1 with DNA. Varying 1 concentrations of PARP1 (60 -250 nM) were mixed in a stopped-flow apparatus with fixed 2 concentrations (30 nM) of a fluorescently labeled model of a double-strand break with a 5'-3 phosphate (p18mer*). Addition of protein results in an increase in fluorescence anisotropy that 4 is not observed by addition of buffer alone ( Fig. 2A) . The data at all concentrations of PARP1 5 could be fitted with a single exponential to yield kobs with very good residuals ( Fig. 2A ). Under 6 idealized experimental conditions wherein the concentration of PARP1 greatly exceeds the 7 concentration of p18mer*, one would expect a replot of kobs vs. the concentration of PARP1 to 8 yield a straight line, as was indeed observed here ( Fig. 2A, inset) . The slope of such a line 9 equals the apparent second order rate constant of association whereas the y-intercept equals 10 the first-order rate constant of dissociation. To analyze the data more rigorously, we used Kintek 11 Explorer, a powerful fitting program that allows for global model-dependent fitting that does not 12 require adherence to limiting conditions ( Fig. 2B ). Our analysis yields a k1 of 3.1 nM -1 s -1 13 (Scheme 1, Table 1 ). The rate of dissociation (k-1) could not be determined from this experiment 
20
Dissociation of PARP1 from DNA requires binding of a second DNA molecule
21
Because we were unable to determine the rate of DNA dissociation from PARP1 in the previous 22 experiment, we designed an experiment to explicitly measure this rate using competition. Here 23 we pre-form a complex between PARP1 and fluorescently labeled DNA and use an excess of 24 unlabeled DNA to compete away the labeled DNA and prevent its re-association with PARP1.
25
We began these investigations by first performing a label-swap experiment to ensure that 26 unlabeled p18mer behaves similarly to fluorescein labeled p18mer*. Since the experimental 27 read-out is based on the change in fluorescence anisotropy of p18mer*, we used a fixed and 28 limiting concentration of total labeled DNA such that no excess p18mer* is present. PARP1 (37 29 nM), pre-bound to either p18mer or p18mer* (25 nM) was mixed with 25 nM p18mer* or p18mer 30 (respectively) in a stopped-flow apparatus. Dissociation of p18mer or p18mer* (followed by 31 binding of the competitor) was monitored by an increase or decrease in fluorescence 32 anisotropy, respectively (Supp. Fig. 1 ). The similarity of these two experiments is best visualized 33 by plotting the sum of the signal to generate a flat line equal to the probe concentration (25 nM), 34 a pseudo-residual indicating that p18mer and p18mer* are kinetically indistinguishable in our 35 assay.
37
In order to probe the mechanism of DNA dissociation from PARP1, we next varied the 
41
>> k-1, Scheme 2), we expect that kobs would be independent of the concentration of competitor 42 DNA. PARP1 (37 nM), pre-bound to p18mer* (25 nM), was mixed with various concentrations of 43 competitor DNA (p18mer, 500 nM -4000 nM) in a stopped-flow apparatus and dissociation of 44 p18mer* was monitored by a decrease in fluorescence anisotropy (Fig. 3) . The data could be 45 fitted to a single exponential to yield kobs with very good residuals ( Fig. 3 ). However, as seen in 46 the data in Fig. 3 by comparing dissociation in the presence of 2.2 vs 4 µM DNA, and in the replot of kobs vs. multiple concentrations of competitor DNA, kobs increases at increasing 48 concentrations of competitor DNA (Fig. 3, inset) . Additionally, attempts to fit these data with 49 Scheme 2 in Kintek Explorer yielded very poor fits and highly skewed residuals (Supp. Fig. 2 ).
6
Thus a different kinetic scheme is needed to fit these data, one where competitor DNA is 1 actively contributing to the dissociation of the pre-bound p18mer*.
3
The simplest model to explain active participation of a competitor DNA in the dissociation of an 4 already bound DNA is formation of a ternary complex wherein the competing DNA binds to 5 PARP1 prior to the dissociation of the pre-bound DNA (Scheme 3). This model consists of four 6 rate constants: k2, (formation of the ternary complex), k-2 (release of the competing DNA to 7 regenerate the pre-bound complex), k3 (release of the pre-bound DNA to generate PARP1 only 8 bound to the competing DNA), and k-3 (re-formation of the ternary complex). Experimentally, 9 both the starting pre-bound complex and the ternary complex are assigned a high anisotropy, 10 whereas the final complex bound only to competing, unlabeled DNA is assigned a low 11 anisotropy. In order to best constrain the four rate constants required to describe Scheme 3, we 12 used a broader range of competing DNA concentrations (50 nM -4000 nM). Also, each 13 concentration series was independently determined and fitted using Kintek Explorer at least 14 three times. Representative fits of this model to the data are shown in Fig. 4, and 
19
quality of the fits with the kinetic model in Scheme 3 provides strong support for the requisite 20 formation of a ternary complex in the dissociation of DNA from PARP1.
22
The second order rate constant of association for the second DNA molecule is 0.043 nM -1 s -1 is 23 almost two orders of magnitude lower than that for association of the first DNA oligomer. The KD 24 for the second DNA strand is 2600 nM, explaining why this complex would be rarely if ever 25 detected under typical experimental conditions performed at nanomolar concentrations of 26 PARP1. Note that the rates of association and dissociation for the second DNA are not 27 "symmetrical" (i.e. k2 ≠ k-3 and k-2 ≠ k3). This asymmetry is most pronounced in the comparison 28 between k-2 and k3: the pre-bound DNA is less likely to dissociate than the second competitor 29 DNA. This observation makes intuitive sense in that the newly incoming DNA presumably binds 30 to a different (weaker) site than the originally more tightly bound DNA. Although there is a lack 31 of symmetry in the rate constants, the kinetically derived dissociation constants (KDs) are quite 32 similar (Supp. Table 1 ).
34
The WGR domain provides the binding site for the second DNA molecule
35
Formation of a ternary complex with two different DNA molecules bound simultaneously 36 requires two separate DNA binding sites. PARP1 has four domains that are known to contribute 37 to DNA binding: Zn1, Zn2, Zn3, and WGR ( Figure 1) . In order to identify if one or more of these 38 domains selectively contributes to the formation of the ternary complex required for efficient 39 DNA release, we generated constructs of PARP1 lacking each of these individual domains. To 40 facilitate proper assembly of the remaining domains, we inserted a flexible 30 amino acid linker 41 into each deletion, except for the N-terminal deletion of Zn1. All mutants were purified to near 42 homogeneity and were tested for DNA-dependent PARylation activity (Supp. Fig. 3 ). As 43 previously reported 21 , Zn1, Zn3, and WGR are essential for catalytic activity, and thus deletion 44 of these domains disrupts PARylation activity. On the other hand, the deletion of the non-45 essential Zn2 domain does not affect PARylation activity.
47
We next measured the rates of association to, and dissociation from p18mer* for each of the 48 individual deletions of the DNA-binding domains, using the stopped-flow anisotropy assays 49 described above. As for wild-type PARP1, each deletion construct was assayed at multiple 50 different concentrations of protein or DNA, and the data were analyzed using global fitting in 51 experiment, the Zn deletions (∆Zn1, ∆Zn2, and ∆Zn3) behaved essentially like wild-type PARP1: 3 increasing competitor DNA concentrations yielded increasing kobs, and the data were best 4 described by global fitting of the kinetic model of Scheme 3 with the formation of a ternary 5 complex (Supp Fig. 5A-C, Table 1 ). In contrast, the ∆WGR mutant behaved dramatically 6 differently; increasing concentrations of competitor DNA did not yield higher kobss, and globally 7 the data were best described by Scheme 2 (Fig. 5A, Table 1 ). In the structure of PARP1 bound 8 to a DSB, Trp589 in the WGR domain stacks against the ribose sugar of the 5'-end of the 9 DNA 15 . Since deletion of the entire WGR domain disrupted formation of the ternary complex, we 10 tested whether the more conservative W589A substitution could recapitulate this effect. PARP1-
11
W589A was prepared (Supp. Fig. 3 ) and tested in both the association and dissociation assays.
12
The W589A point mutation is properly folded, as the mutant and wild-type PARP1 have identical 13 melting temperatures (43.9 ± 0.3 vs. 43.3 ± 0.3 °C). Similar to what was observed with the 14 deletion of the entire WGR domain, the W589A mutant also bound to free DNA rapidly (Supp. 15 Fig. 6 ), and released DNA via the simple mechanism in Scheme 2 that is not dependent on 16 binding a second DNA molecule (Fig. 5B, Table 1 ).
18
The W589A mutant shows reduced accumulation at sites of DNA damage in cells
19
In order to test the physiological relevance of the mechanism of DNA-dependent release of DNA 20 from PARP1 revealed in our in vitro experiments, we compared the rate and magnitude of 21 accumulation of wild-type PARP1 with the W589A mutant at sites of DNA damage in cells.
22
Mouse embryo fibroblasts were transiently transfected with GFP-tagged PARP1 (wild-type or 23 W589A), and DNA damage was induced by laser microirradiation at a designated region of 24 interest (ROI) within the nucleus. Accumulation of PARP1 in the ROI was monitored by confocal 25 microscopy for 1 -5 min and the diffusion coefficient (Deff) and magnitude of PARP1 26 accumulation (F) were derived as recently described (Mahadevan et al., in preparation) . As 27 seen in Table 2 , the W589A mutant accumulated to a lower level and with a significantly slower 28 diffusion coefficient than wild-type PARP1.
30
High affinity inhibitors of PARP1 do not alter the rate or mechanism of DNA dissociation 31 Given the uncertain experimental basis for PARP1 trapping on DNA in cells treated with 32 clinically relevant inhibitors of PARP1 34 , we used the rigorous in vitro assay described above to 33 investigate whether these inhibitors lead to a change in the rate or mechanism of DNA 34 dissociation. We monitored the dissociation of p18mer* from PARP1 by fluorescence anisotropy 35 in the presence of four different tight-binding inhibitors of PARP1, using 1 µM competitor 36 p18mer. The observed dissociation curves were fit with a first order exponential and the 37 calculated rates were essentially identical to the DMSO control for olaparib, veliparib, niraparib, 38 and talazoparib ( Fig 6A) . To ensure that in the presence of inhibitor, DNA dissociation was still 39 dependent on binding of competitor DNA (Scheme 3), we investigated the DNA concentration 40 dependence of p18mer* dissociation in the presence of talazoparib, the most potent PARP1-41 trapping compound 34 . The dissociation of p18mer* in the presence of talazoparib (50 nM) was 42 measured at varying concentrations of competitor p18mer (1 -4 µM) and a concentration-43 dependent increase in kobs was observed just as for the control without inhibitor (Fig. 6B ). We 44 conclude that these inhibitors do not change the rate or mechanism of DNA dissociation from stranded DNA are 0.002, 0.004, 0.13, and 0.6 -1.4 nM -1 s -1 , respectively, effectively spanning 7 three orders of magnitude. The fast association of PARP1 with DNA means that when 8 dissociation does occur, re-association is most likely to the same site on the same DNA, as 9 association is faster than diffusion carrying PARP1 away from its original binding site. This 10 observation suggests that PARP1, like other DNA-binding proteins such as transcription 11 factors 25 , must have a mechanism for moving around the genome that does not rely on simple 12 dissociation and re-association. Although protein sliding along DNA in one-dimension has 13 previously been invoked as a potential mechanism for accelerating the search for specific 14 binding sites 30 , more recent publications point out potential difficulties with such a long-distance 15 sliding model 47 , which is even more difficult to envision given the organization of DNA into 16 nucleosomes in the eukaryotic genome.
18
Instead, we have found that PARP1 dissociation from DNA is triggered by binding of an 19 additional DNA oligomer prior to dissociation from the first DNA oligomer. We envision a 20 "monkey bar" model 48,49 , wherein PARP1 moves from one DNA molecule to another DNA 21 molecule, much like a child swings from bar to bar, transferring one hand at a time. This 22 mechanism allows PARP1 to effectively scan the genome, moving to new and different sections 23 of DNA. In the absence of competing DNA, PARP1 would remain effectively stuck at or near 24 one site given its fast rate of association. We have found that the WGR domain provides the 25 other weaker "hand" to facilitate the movement from one DNA strand to the next. Based on the 
35
A recent study of PARP1 using single molecule DNA tightrope assays provides strong evidence 36 for such a monkey bar mechanism 24 . It was shown that micro-dissociation of one of PARP1's 37 multiple DNA binding domains from DNA allows it to bind to a free 37 bp fragment, thus 38 preventing rebinding of the domain to the tightrope and accelerating overall macro-dissociation.
39
Our mechanism for DNA-dependent DNA dissociation also provides a compelling explanation 40 for the wide diversity and significantly weaker dissociation constants previously reported for 41 PARP1 with DNA 16,21,40 : the measured apparent KD depends strongly on the experimental 
45
Strong in vitro evidence for a monkey bar mechanism, also known as intersegment transfer, uses its three Zn fingers to both bind and scan other DNA fragments as it moves between 1 different recognition sites on different DNA molecules 26 . Interestingly, mutagenesis of specific 2 residues in EgrI was used to shift the equilibrium between binding and scanning modes.
4
One major caveat to any biochemical investigation of the mechanism of DNA -protein 5 interactions is the artificial nature of a DNA oligomer compared to intact chromatin. This 6 limitation affects studies of PARP1 interactions with DNA in particular because it is quite difficult 7 to prepare completely intact DNA without ends or nicks, preferably wrapped around 8 nucleosomes. Thus, it was important to test the significance of the monkey bar mechanism in a 9 more physiologically relevant model. We have demonstrated the validity of interstrand transfer 10 in vivo by demonstrating that the point mutant W589A, which disrupts DNA-dependent release 11 of DNA, accumulates slower and to a lesser amount than wild-type PARP1 at sites of laser 12 microirradiation ( Table 2 ). The slower accumulation of W589A in cells is a particularly powerful 13 demonstration of the importance of the monkey bar mechanism for PARP1 in finding sites of 14 DNA damage for two reasons. First, the rate of dissociation for W589A from DNA is greater than 15 for wild-type (20 s -1 vs. <10 s -1 ). Second, the apparent KD of W589A for DNA is weaker than that 16 of wild-type PARP1 (5 nM vs. <3 nM, respectively). Simplistically, these two observations might 17 suggest that W589A should arrive at sites of DNA damage more rapidly than wild-type PARP1 18 since its interaction with DNA is not as tight or as long-lived (i.e. it spends less time occupying 19 irrelevant sites); yet we observe the opposite. The monkey bar mechanism provides the 20 explanation for these results: high concentrations of intranuclear DNA allow PARP1 to explore 21 the nucleus so fast. A dysfunctional monkey (W589A) surrounded by a lot of DNA does not 22 move as rapidly. Thus, we have quantitatively demonstrated the importance of intersegment 23 transfer in the accumulation of a DNA-binding protein at its target destination in vivo.
25
Finally, our results also provide further insight into the much-discussed topic of PARP1 26 "trapping", wherein cells treated with inhibitors of PARP1 exhibit a shift of PARP1 from the 27 soluble fraction to a chromatin-associated insoluble fraction 35 . Many cell-based studies have 28 since confirmed the phenomenon of PARP-trapping 36 . Our data showing no effect of four 29 different tight-binding inhibitors of PARP1 on the release of DNA agree with a previous thorough 30 biochemical analysis that also could not find any effects of inhibitors on DNA binding constants 31 or rates of dissociation 37 . Thus, the mechanistic basis for PARP-trapping appears to be more 32 complex than can be reconstituted in vitro .   33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51 k1 (nM -1 s -1 ) k-1 (s -1 ) k2 (nM -1 s -1 ) k-2 (s -1 ) k3 (s -1 ) k-3 (nM -1 s -1 ) All values (mean and standard deviation) were derived from the kinetic parameters in Table 1. 10 11 
